April 10, 2026 03:14 pm (IST)
GlaxoSmithKline records 11% growth for Q2
New Delhi, Nov 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the second quarter ended September 30, 2014.
The company's net sales were reported at Rs 1075 crores, which recorded a growth of 11% over 2013 with PAT at Rs. 160 crores growing by 9% for the same period and PBT at Rs 245 crores growing by 10%.
Commenting on the results, Zubair Ahmed, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “We are delighted to have delivered consistent growth as the category leader. The consumer sentiments are showing early signs of recovery and our brands are well poised to help consumers do more, feel better and live longer. Our relentless focus on science, innovation and customer, remains our key differentiator and helps us to stay ahead in the category."
"We continue to improve consumer’s experience with new products like the re-launched Horlicks with proven health benefits, ‘instantization’ and new positioning, highlighting its daily nutritional relevance. We also remain focused on our access strategy to ensure that our products are within the easy reach of our large consumer base,” Ahmed said.
Support Our Journalism
We cannot do without you.. your contribution supports unbiased journalism
IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.
Support objective journalism for a small contribution.
Latest Headlines
From Oracle layoffs in the US to an India comeback: Couple’s emotional story goes viral
Fri, Apr 10 2026
South Asia remains fastest-growing region; India continues as growth engine: World Bank
Thu, Apr 09 2026
AI impact: Dell cuts 11,000 jobs in strategic workforce trim
Thu, Apr 09 2026
TCS gains ahead of Q4 earnings; street eyes growth signals
Thu, Apr 09 2026
Meesho shares soar 14% — stock now 55% above IPO price!
Thu, Apr 09 2026
Sensex falls 800 points, Nifty slips as oil surges on US-Iran ceasefire uncertainty
Thu, Apr 09 2026
IndiGo shares soar 11%: What’s behind the rally?
Wed, Apr 08 2026
Realty, auto stocks rally after US-Iran ceasefire deal
Wed, Apr 08 2026
